We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
-36.43%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
AUM
$20.1M
AUM Growth
-$13.6M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Communication Services 64.37%
2 Healthcare 35.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIRY
1
Firy Inc
FIRY
$163M
$11.6M 57.68%
1,145,493
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$2.42M 12.02%
2,945,453
SPRO icon
3
Spero Therapeutics
SPRO
$72.4M
$2.38M 11.85%
1,376,968
SYBX
4
DELISTED
Synlogic
SYBX
$2.02M 10.03%
176,798
SNAP icon
5
Snap
SNAP
$9.01B
$1.34M 6.69%
150,160
NTLA icon
6
Intellia Therapeutics
NTLA
$1.65B
$349K 1.74%
10,000

Similar funds

Atlas Venture Associates IX's Q4 2022 Portfolio in Review

As of Q4 2022, Atlas Venture Associates IX held 6 positions worth $20.1M, down 40% from $33.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 0%. Atlas Venture Associates IX opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 64% of assets, down from 74% a quarter earlier, followed by Healthcare.

  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $20.1M portfolio in Q4 2022.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q4 2022.
  • Atlas Venture Associates IX's portfolio value fell 40% quarter-over-quarter to $20.1M.

Based on Atlas Venture Associates IX's 13F filing for Q4 2022, filed 31 Jan 2023.